Adam Kievman was Appointed as Senior Director, Global Talent Acquisition Leader at Alnylam

Date of management change: July 15, 2015 

What Happened?

Cambridge, MA-based Alnylam Appointed Adam Kievman as Senior Director, Global Talent Acquisition Leader

 

About the Company

Alnylam is the world`s leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market. We are developing RNAi (RNA interference) as an innovative, entirely new class of medicines to treat rare genetic, cardio metabolic, acute hepatic infectious and central nervous system (CNS) and ocular diseases. Alnylam was founded in 2002 based on a Nobel Prize-winning breakthrough in biology – the discovery of RNAi, and a bold vision that this discovery could be used to silence disease-causing genes upstream of today`s medicines. We are relentless in our pursuit of new treatments because we believe that RNAi therapeutics can be used to treat many diseases for which treatment options do not exist or are inadequate. Overall, we believe that patients shouldn`t have to wait for hope. Alnylam is turning scientific possibility into reality - in 2018, the FDA and European EMA approved of our first product, ONPATTRO (patisiran) which is also the first-ever approved RNAi therapeutic. In 2019, the FDA approved our second product, GIVLAARI (givosiran). Our robust pipeline of investigational medicines includes multiple programs in late-stage and early-stage clinical development. We are a global and diverse company of more than 1,500 people. We pride ourself on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That`s why we`ve been named a Science Magazine Top Employer for two years in a row (`19-`20), a Boston Globe Top Place to Work 5x in a row (`15-`19) and one of Fast Company`s 50 Most Innovative Companies for 2019. We are based in Cambridge, U.S., with offices throughout Europe, Asia and South America.

 

About the Person

Adam Kievman serves as Senior Director, Global Talent Acquisition Leader at Alnylam Pharmaceuticals since July 2015. He completed his graduation from Emory University - Goizueta Business School.

 

Info Source

Company Announcement

 
 

Other IT executives who recently changed jobs as well: Stein Diane, Tiwary Abhishek, Johnson Nate, Lee Kelly, Carroll Melanna, Thompson Jana, Glimp Thomas, Gascoigne Shantel, Graziano Mike, Greer Linda, Evans Nathaniel

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.